Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard to make ...

Geneos Wealth Management Inc. purchased a new stake in shares of GSK plc (NYSE:GSK – Free Report) during the fourth quarter, ...

GSK share price remains in a deep bear market after falling by 21% ... pressure in the past few months as investors watch the ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

GSK PLC closed 23.91% below its 52-week high of £18.24, which the company reached on May 16th.

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

These price increases are likely to affect ... If you are looking for an AI stock that is more promising than GSK but that trades at less than 5 times its earnings, check out our report about ...